Editas Medicine, Inc. (LON:0IFK)

Editas Medicine Revenue

Editas Medicine had revenue of $4.66M USD in the quarter ending March 31, 2025, with 310.40% growth. This brings the company's revenue in the last twelve months to $35.84M, down -48.37% year-over-year. In the year 2024, Editas Medicine had annual revenue of $32.31M, down -58.64%.

• Revenue (ttm): $35.84M
• Revenue Growth: -48.37%
• P/S Ratio: 5.68
• Revenue / Employee: $145.68K
• Employees: 246
• Market Cap: 157.54M GBP

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	32.31M	-45.81M	-58.64%
Dec 31, 2023	78.12M	58.41M	296.32%
Dec 31, 2022	19.71M	-5.83M	-22.83%
Dec 31, 2021	25.54M	-65.19M	-71.85%
Dec 31, 2020	90.73M	70.20M	341.93%